Primus brings synthetic biology to the production of fine chemicals. Founded by MIT and Harvard researchers, Primus' tech reduces the cost of producing valuable chemicals by 10X, with implications for industries from health to food and nutrition. We identified a set of applications with a collective market over $2B. Primus is seeking funding for a demo for one application - shikimic acid that is a critical precursor for the production of Tamiflu, the most effective anti-viral for influenza.

2010 Boston Finalist